Logo

Lansing Taylor, Jorgine Ellerbrock

Dec 13, 2007
Premium
The Pittsburgh Life Sciences Greenhouse has named Lansing Taylor as its chairman.
 
Taylor takes over for Co-chairs Mark Nordenberg and Jared Cohon.
 
He is already on the board of PLSG and recently served as chairman and CEO of high-content cell screening firm Cellomics, which he founded and was acquired by Thermo Fisher Scientific in September 2005. He also was a co-founder, member of the board, and scientific advisor to Biological Detection Systems, which was sold to Amersham Biosciences in 1996
 
 
Jorgine Ellerbrock has been named senior VP of operations at Gen-Probe.
 
Ellerbrock formerly was VP of operations at Invitrogen’s molecular biology business, and before that she was at GE Healthcare Biosciences, where she was VP of operations and VP of genomics product management. She also held various posts at Roche.

Filed under

Gene Silencing/Gene Editing
RNAi
Breaking News
The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.